Zipprick, J.; Demir, E.; Krynska, H.; Köprülüoğlu, S.; Strauß, K.; Skribek, M.; Hutyra-Gram Ötvös, R.; Gad, A.K.B.; Dobra, K.
Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis. Cancers 2025, 17, 986.
https://doi.org/10.3390/cancers17060986
AMA Style
Zipprick J, Demir E, Krynska H, Köprülüoğlu S, Strauß K, Skribek M, Hutyra-Gram Ötvös R, Gad AKB, Dobra K.
Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis. Cancers. 2025; 17(6):986.
https://doi.org/10.3390/cancers17060986
Chicago/Turabian Style
Zipprick, Jenny, Enes Demir, Hanna Krynska, Sıla Köprülüoğlu, Katharina Strauß, Marcus Skribek, Rita Hutyra-Gram Ötvös, Annica K. B. Gad, and Katalin Dobra.
2025. "Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis" Cancers 17, no. 6: 986.
https://doi.org/10.3390/cancers17060986
APA Style
Zipprick, J., Demir, E., Krynska, H., Köprülüoğlu, S., Strauß, K., Skribek, M., Hutyra-Gram Ötvös, R., Gad, A. K. B., & Dobra, K.
(2025). Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis. Cancers, 17(6), 986.
https://doi.org/10.3390/cancers17060986